Platelet-Rich Plasma for Peyronie's Disease

NARecruitingINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

September 20, 2025

Primary Completion Date

June 1, 2028

Study Completion Date

September 1, 2028

Conditions
Peyronies Disease
Interventions
OTHER

Autologous Platelet Rich Plasma

6 mL PRP intralesional injections will be administered. After the injections, participants will be instructed to perform penile stretching exercises daily until the next injection and to continue these exercises after the final injection until the 3-month follow-up.

OTHER

Saline solution

6 mL saline solution intralesional injections will be administered. After the injections, participants will be instructed to perform penile stretching exercises daily until the next injection and to continue these exercises after the final injection until the 3-month follow-up.

Trial Locations (1)

2100

RECRUITING

Herlev and Gentofte University Hospital, Herlev

All Listed Sponsors
lead

Herlev Hospital

OTHER

NCT07117955 - Platelet-Rich Plasma for Peyronie's Disease | Biotech Hunter | Biotech Hunter